{"disease":{"id":"advanced-liver-cancer","name":"advanced liver cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04524871","title":"A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":518,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT02072356","title":"Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":290,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT04906434","title":"A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Abbisko Therapeutics Co, Ltd","has_results":false},{"nct_id":"NCT03092895","title":"A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":true},{"nct_id":"NCT03166553","title":"Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"BeiJing Yijiayi Medicine Techonoloy Co., Ltd.","has_results":false},{"nct_id":"NCT03146637","title":"Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.","has_results":false},{"nct_id":"NCT05603039","title":"A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Qilu Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03474822","title":"Plasmodium Immunotherapy for Breast and Liver Cancers","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"CAS Lamvac Biotech Co., Ltd.","has_results":false},{"nct_id":"NCT04163237","title":"Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Guangxi Medical University","has_results":false},{"nct_id":"NCT05098197","title":"A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Shanghai Juncell Therapeutics","has_results":false},{"nct_id":"NCT03167775","title":"Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"BeiJing Yijiayi Medicine Techonoloy Co., Ltd.","has_results":false},{"nct_id":"NCT01666756","title":"Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT05411757","title":"IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"Shandong Public Health Clinical Center","has_results":false},{"nct_id":"NCT06173726","title":"Investigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection in the Treatment of Locally Advanced/Metastatic Liver Cancer","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":6,"lead_sponsor_name":"BioSyngen Pte Ltd","has_results":false},{"nct_id":"NCT02119065","title":"Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6,"lead_sponsor_name":"University of Cincinnati","has_results":false},{"nct_id":"NCT03484962","title":"Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Fuda Cancer Hospital, Guangzhou","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}